Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7080)
All Articles published online
|
May 15, 2012 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cardinale V, Carpino G, Reid L, Gaudio E, Alvaro D. Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. World J Gastrointest Oncol 2012; 4(5): 94-102 [PMID: 22645632 DOI: 10.4251/wjgo.v4.i5.94] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v4/i5/94.htm |
| Number | Citing Articles |
| 1 |
Vincenzo Cardinale, Anastasia Renzi, Guido Carpino, Alessia Torrice, Maria C. Bragazzi, Felice Giuliante, Agostino M. De Rose, Alice Fraveto, Paolo Onori, Chiara Napoletano, Antonio Franchitto, Alfredo Cantafora, GianLuca Grazi, Nicola Caporaso, Giuseppe D'Argenio, Gianfranco Alpini, Lola M. Reid, Eugenio Gaudio, Domenico Alvaro. Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas. The American Journal of Pathology 2015; 185(6): 1724 doi: 10.1016/j.ajpath.2015.02.010
|
| 2 |
Szilvia Lilla Csoma, Judit Bedekovics, Gergő Veres, Anita Árokszállási, Csilla András, Gábor Méhes, Attila Mokánszki. Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022; 14(1): 233 doi: 10.3390/cancers14010233
|
| 3 |
Ijin Joo. Recent Updates in the Imaging Diagnosis of Cholangiocarcinoma. Journal of the Korean Society of Radiology 2019; 80(3): 394 doi: 10.3348/jksr.2019.80.3.394
|
| 4 |
Pier Francesco Ferrucci, Emilia Cocorocchio, Guido Bonomo, Gianluca Maria Varano, Paolo Della Vigna, Franco Orsi. A New Option for the Treatment of Intrahepatic Cholangiocarcinoma: Percutaneous Hepatic Perfusion with CHEMOSAT Delivery System. Cells 2021; 10(1): 70 doi: 10.3390/cells10010070
|
| 5 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 605 doi: 10.1007/978-3-319-26956-6_31
|
| 6 |
Pedro M. Rodrigues, Paula Olaizola, Nuno A. Paiva, Irene Olaizola, Alona Agirre-Lizaso, Ana Landa, Luis Bujanda, Maria J. Perugorria, Jesus M. Banales. Pathogenesis of Cholangiocarcinoma. Annual Review of Pathology: Mechanisms of Disease 2021; 16(1): 433 doi: 10.1146/annurev-pathol-030220-020455
|
| 7 |
Kyu Sik Jung, Kyeong Hyeon Chun, Gi Hong Choi, Hyae Min Jeon, Hye Sun Shin, Young Nyun Park, Jun Yong Park. Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports. BMC Research Notes 2013; 6(1) doi: 10.1186/1756-0500-6-520
|
| 8 |
Xiaobo Cai, Jun Li, Xiaodong Yuan, Jingbo Xiao, Steven Dooley, Xinjian Wan, Honglei Weng, Lungen Lu. CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma. Journal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1423-9
|
| 9 |
Carlie S. Sigel, Esther Drill, Yi Zhou, Olca Basturk, Gokce Askan, Linda M. Pak, Efsevia Vakiani, Tao Wang, Thomas Boerner, Richard K.G. Do, Amber L. Simpson, William Jarnagin, David S. Klimstra. Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns. American Journal of Surgical Pathology 2018; 42(10): 1334 doi: 10.1097/PAS.0000000000001118
|
| 10 |
Gábor Lendvai, Tímea Szekerczés, Idikó Illyés, Réka Dóra, Endre Kontsek, Alíz Gógl, András Kiss, Klára Werling, Ilona Kovalszky, Zsuzsa Schaff, Katalin Borka. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis. Pathology & Oncology Research 2020; 26(1): 3 doi: 10.1007/s12253-018-0491-8
|
| 11 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
|
| 12 |
Francesca Vita, Irene Olaizola, Francesco Amato, Colin Rae, Sergi Marco, Jesus M. Banales, Chiara Braconi. Heterogeneity of Cholangiocarcinoma Immune Biology. Cells 2023; 12(6): 846 doi: 10.3390/cells12060846
|
| 13 |
Steffen Zender, Irina Nickeleit, Torsten Wuestefeld, Inga Sörensen, Daniel Dauch, Przemyslaw Bozko, Mona El-Khatib, Robert Geffers, Hueseyin Bektas, Michael P. Manns, Achim Gossler, Ludwig Wilkens, Ruben Plentz, Lars Zender, Nisar P. Malek. A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas. Cancer Cell 2013; 23(6): 784 doi: 10.1016/j.ccr.2013.04.019
|
| 14 |
Ju Gang Nam, Jeong Min Lee, Ijin Joo, Su Joa Ahn, Jin Young Park, Kyoung Bun Lee, Joon Koo Han. Intrahepatic Mass-Forming Cholangiocarcinoma: Relationship Between Computed Tomography Characteristics and Histological Subtypes. Journal of Computer Assisted Tomography 2018; 42(3): 340 doi: 10.1097/RCT.0000000000000695
|
| 15 |
Chaobo Chen, Leonard J. Nelson, Matías A. Ávila, Francisco Javier Cubero. Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link. Cells 2019; 8(10): 1172 doi: 10.3390/cells8101172
|
| 16 |
Hung-Chune Maa, Pham van Tuyen, Yen-Lin Chen, Yao-Nan Yuan. MCRS1 EXPRESSION MORE IN TUMOR PART AND SERVES AS A POOR PROGNOSTIC FACTOR IN EXTRAHEPATIC CHOLANGIOCARCINOMA. GLOBAL JOURNAL FOR RESEARCH ANALYSIS 2021; : 72 doi: 10.36106/gjra/7809476
|
| 17 |
Ijin Joo, Jeong Min Lee, Jeong Hee Yoon. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology 2018; 288(1): 7 doi: 10.1148/radiol.2018171187
|
| 18 |
Winnie A. Mar, Hing Kiu Chan, Surbhi B. Trivedi, Senta M. Berggruen. Imaging of Intrahepatic Cholangiocarcinoma. Seminars in Ultrasound, CT and MRI 2021; 42(4): 366 doi: 10.1053/j.sult.2021.04.001
|
| 19 |
Jesper B. Andersen. Molecular pathogenesis of intrahepatic cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2): 101 doi: 10.1002/jhbp.155
|
| 20 |
Hector Perez-Montoyo. Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma. Cells 2020; 9(3): 614 doi: 10.3390/cells9030614
|
| 21 |
Saumya Jayakumar, Mary Lee Krinsky. Encyclopedia of Gastroenterology. 2020; : 470 doi: 10.1016/B978-0-12-801238-3.65865-8
|
| 22 |
Giulia Anichini, Laura Carrassa, Barbara Stecca, Fabio Marra, Chiara Raggi. The Role of the Hedgehog Pathway in Cholangiocarcinoma. Cancers 2021; 13(19): 4774 doi: 10.3390/cancers13194774
|
| 23 |
Vincenzo Cardinale, Maria Consiglia Bragazzi, Guido Carpino, Alessia Torrice, Yunfang Wang, Lola McAdams Reid, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinomas: New Insights from the Discovery of Stem Cell Niches in Peribiliary Glands of the Biliary Tree. Advances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/794953
|
| 24 |
Tsunekazu Oikawa. Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers. Hepatology 2016; 64(2): 645 doi: 10.1002/hep.28485
|
| 25 |
Antonio Cigliano, Xin Chen, Diego F. Calvisi. Current challenges to underpinning the genetic basis for cholangiocarcinoma. Expert Review of Gastroenterology & Hepatology 2021; 15(5): 511 doi: 10.1080/17474124.2021.1915128
|
| 26 |
Wencheng Zhang, Yangyang Cui, Yuan Du, Yong Yang, Ting Fang, Fengfeng Lu, Weixia Kong, Canjun Xiao, Jun Shi, Lola M. Reid, Zhiying He. Liver cell therapies: cellular sources and grafting strategies. Frontiers of Medicine 2023; 17(3): 432 doi: 10.1007/s11684-023-1002-1
|
| 27 |
Rosa B. Schmuck, Cynthia V. de Carvalho‐Fischer, Christopher Neumann, Johann Pratschke, Marcus Bahra. Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity. Cancer Medicine 2016; 5(1): 88 doi: 10.1002/cam4.566
|
| 28 |
Abdulkadir Isidan, Ali Yenigun, Daiki Soma, Eric Aksu, Kevin Lopez, Yujin Park, Arthur Cross-Najafi, Ping Li, Debjyoti Kundu, Michael G. House, Sanjukta Chakraborty, Shannon Glaser, Lindsey Kennedy, Heather Francis, Wenjun Zhang, Gianfranco Alpini, Burcin Ekser. Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines. The American Journal of Pathology 2022; 192(9): 1200 doi: 10.1016/j.ajpath.2022.05.007
|
| 29 |
Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 321 doi: 10.1016/bs.acr.2020.10.005
|
| 30 |
Sumera I. Ilyas, Gregory J. Gores. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Gastroenterology 2013; 145(6): 1215 doi: 10.1053/j.gastro.2013.10.013
|
| 31 |
Miaoyan Wei, Lisheng Lü, Peiyi Lin, Zhisheng Chen, Zhiwei Quan, Zhaohui Tang. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma. Cancer Letters 2016; 379(2): 253 doi: 10.1016/j.canlet.2016.02.038
|
| 32 |
Sukanya Roy, Shannon Glaser, Sanjukta Chakraborty. Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms. Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00293
|
| 33 |
Mingyu Yang, Meng Li, Zhuozhen Lyu, Zhen Yang. Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?. Cancer Management and Research 2023; : 335 doi: 10.2147/CMAR.S406150
|
| 34 |
Kyoungbun Lee, Young Seok Song, Yoonju Shin, Xianyu Wen, Younghoon Kim, Nam-Yun Cho, Jeong Mo Bae, Gyeong Hoon Kang. Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological features. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72810-0
|
| 35 |
Joy A Awosika, Cecilia Monge, Tim F Greten. Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape. Hepatic Oncology 2024; 11(1) doi: 10.1080/20450923.2024.2403334
|
| 36 |
Maria Zulfiqar, Deyali Chatterjee, Norihide Yoneda, Mark J. Hoegger, Maxime Ronot, Elizabeth M. Hecht, Nina Bastati, Ahmed Ba-Ssalamah, Mustafa R. Bashir, Kathryn Fowler. Imaging Features of Premalignant Biliary Lesions and Predisposing Conditions with Pathologic Correlation. RadioGraphics 2022; 42(5): 1320 doi: 10.1148/rg.210194
|
| 37 |
Zhiliang Wu, Thidarut Boonmars, Isao Nagano, Sirintip Boonjaraspinyo, Piyarat Srinontong, Panaratana Ratasuwan, Khuntikeo Narong, Phuangphaka Sadee Nielsen, Yoichi Maekawa. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis‐associated cholangiocarcinoma. International Journal of Cancer 2016; 138(2): 396 doi: 10.1002/ijc.29721
|
| 38 |
Sravanthi Mantripragada, Ashish Chawla. Cholangiocarcinoma: Part 1, Pathological and Morphological Subtypes, Spectrum of Imaging Appearances, Prognostic Factors and Staging. Current Problems in Diagnostic Radiology 2022; 51(3): 351 doi: 10.1067/j.cpradiol.2021.03.008
|
| 39 |
Ijin Joo, Haeryoung Kim, Jeong Min Lee. Cancer Stem Cells in Primary Liver Cancers: Pathological Concepts and Imaging Findings. Korean Journal of Radiology 2015; 16(1): 50 doi: 10.3348/kjr.2015.16.1.50
|
| 40 |
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2020; 17(9): 557 doi: 10.1038/s41575-020-0310-z
|
| 41 |
Iris E.M. de Jong, Otto B. van Leeuwen, Ton Lisman, Annette S.H. Gouw, Robert J. Porte. Repopulating the biliary tree from the peribiliary glands. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1524 doi: 10.1016/j.bbadis.2017.07.037
|
| 42 |
Yasuni Nakanuma, Takashi Miyata, Tsuneyuki Uchida. Latest advances in the pathological understanding of cholangiocarcinomas. Expert Review of Gastroenterology & Hepatology 2016; 10(1): 113 doi: 10.1586/17474124.2016.1104246
|
| 43 |
Zhenyang Shen, Jingbo Xiao, Junjun Wang, Lungen Lu, Xinjian Wan, Xiaobo Cai. Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01471-0
|
| 44 |
Sai Sandeep Annamaraju, Sai Charitha Mullaguri, Ravikanth Vishnubhotla, Rama Krishna Kancha. Biomedical Aspects of Solid Cancers. 2024; : 85 doi: 10.1007/978-981-97-1802-3_8
|
| 45 |
Larissa Muething, James R. Burton. Primary Sclerosing Cholangitis. 2017; : 13 doi: 10.1007/978-3-319-40908-5_2
|
| 46 |
Alphonse E. Sirica, Roberto J. Groszmann, Yasuko Iwakiri, Tamar H. Taddei. Notching up on the cellular origins of intrahepatic cholangiocarcinoma. Hepatology 2013; 57(4): 1668 doi: 10.1002/hep.26313
|
| 47 |
A. Sabaté-Llobera, L. Gràcia-Sánchez, G. Reynés-Llompart, E. Ramos, L. Lladó, J. Robles, T. Serrano, J. Mestres-Martí, C. Gámez-Cenzano. Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG–PET/CT: prognostic implication of metabolic parameters and tumor markers. Clinical and Translational Oncology 2019; 21(3): 324 doi: 10.1007/s12094-018-1926-0
|
| 48 |
Kristen Spencer, Leontios Pappas, Islam Baiev, Jordan Maurer, Andrea Grace Bocobo, Karen Zhang, Apurva Jain, Anaemy Danner De Armas, Stephanie Reyes, Tri Minh Le, Osama E Rahma, Jennifer Stanton, Thomas T DeLeon, Marc Roth, Mary Linton B Peters, Andrew X Zhu, Jochen K Lennerz, A John Iafrate, Kylie Boyhen, Christine VanCott, Lewis R Roberts, Stacie Lindsey, Nora Horick, Laura Williams Goff, Kabir Mody, Mitesh J Borad, Rachna T Shroff, Robin Kate Kelley, Milind M Javle, Lipika Goyal. Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. JNCI: Journal of the National Cancer Institute 2023; 115(7): 870 doi: 10.1093/jnci/djad046
|
| 49 |
Myeong-Jin Kim, Hyungjin Rhee, Ha Young Woo. A dichotomous imaging classification for cholangiocarcinomas based on new histologic concepts. European Journal of Radiology 2019; 113: 182 doi: 10.1016/j.ejrad.2019.02.025
|
| 50 |
Mackenzie Owen, Mina S. Makary, Eliza W. Beal. Locoregional Therapy for Intrahepatic Cholangiocarcinoma. Cancers 2023; 15(8): 2384 doi: 10.3390/cancers15082384
|
| 51 |
Richard K. Do, Daniel T. Boll. Diseases of the Abdomen and Pelvis 2023-2026. IDKD Springer Series 2023; : 121 doi: 10.1007/978-3-031-27355-1_8
|
| 52 |
Takeshi Makiuchi, Tomotaka Sobue, Tetsuhisa Kitamura, Junko Ishihara, Norie Sawada, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Shoichiro Tsugane. Relationship between Meat/Fish Consumption and Biliary Tract Cancer: The Japan Public Health Center–Based Prospective Study. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(1): 95 doi: 10.1158/1055-9965.EPI-19-0514
|
| 53 |
Inyoung Cheon, Minwook Kim, Kang Ho Kim, Sungjin Ko. Hepatic Nuclear Receptors in Cholestasis-to-Cholangiocarcinoma Pathology. The American Journal of Pathology 2024; doi: 10.1016/j.ajpath.2024.07.023
|
| 54 |
Vincenzo Cardinale, Guido Carpino. Multilevel heterogeneity of biliary tract cancers may affect the modelling of prognosis. Liver International 2017; 37(12): 1773 doi: 10.1111/liv.13565
|
| 55 |
Giuseppe Losurdo, Antonietta Gerarda Gravina, Luca Maroni, Enrico Maria Gabrieletto, Gianluca Ianiro, Alberto Ferrarese, Alessia Visintin, Leonardo Frazzoni, Gaia Pellegatta, Anna Sessa, Loris Lopetuso, Serena Porcari. Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective. Digestive and Liver Disease 2022; 54(5): 583 doi: 10.1016/j.dld.2021.08.008
|
| 56 |
Daniel H. Ahn, Tanios Bekaii-Saab. Textbook of Gastrointestinal Oncology. 2019; : 185 doi: 10.1007/978-3-030-18890-0_11
|
| 57 |
Tomoki Yagai, Satoshi Matsui, Kenichi Harada, Fuyuki F. Inagaki, Eiko Saijou, Yasushi Miura, Yasuni Nakanuma, Atsushi Miyajima, Minoru Tanaka, Matias A Avila. Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree. PLOS ONE 2017; 12(4): e0175355 doi: 10.1371/journal.pone.0175355
|
| 58 |
Joanna Socha, Maciej Michalak, Grzegorz Wołąkiewicz, Lucyna Kepka. Nodal areas of potential geographic error in adjuvant radiotherapy for biliary tract cancer. Radiotherapy and Oncology 2017; 125(2): 365 doi: 10.1016/j.radonc.2017.09.025
|
| 59 |
Marcus Bahra, Ali Yahyazadeh. Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC). Cancers 2023; 15(3): 774 doi: 10.3390/cancers15030774
|
| 60 |
Chiara Raggi, Pietro Invernizzi, Jesper B. Andersen. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts. Journal of Hepatology 2015; 62(1): 198 doi: 10.1016/j.jhep.2014.09.007
|
| 61 |
Alexander Arnold, Marcus Bahra, Dido Lenze, Maren Bradtmöller, Katrin Guse, Claire Gehlhaar, Hendrik Bläker, Frank L. Heppner, Arend Koch. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay. Experimental and Molecular Pathology 2015; 99(2): 344 doi: 10.1016/j.yexmp.2015.08.003
|
| 62 |
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 261 doi: 10.1038/nrgastro.2016.51
|
| 63 |
Younghoon Kim, Kyoungbun Lee, Seorin Jeong, Xianyu Wen, Nam-Yun Cho, Gyeong Hoon Kang. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype. Virchows Archiv 2019; 475(1): 49 doi: 10.1007/s00428-018-02511-7
|
| 64 |
Giovanni Brandi, Andrea Farioli, Annalisa Astolfi, Guido Biasco, Simona Tavolari. Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies. Oncotarget 2015; 6(17): 14744 doi: 10.18632/oncotarget.4539
|
| 65 |
Leonard M. Quinn, Nicholas Bird, Robert Jones, David Vass, Hassan Malik. Liver Cancers. 2019; : 199 doi: 10.1007/978-3-319-92216-4_16
|
| 66 |
Vincenzo Cardinale, Domenico Alvaro. PTPN3 Mutations and HBV May Exert Synergistic Effects in the Origin of the Intrahepatic Cholangiocarcinoma. Gastroenterology 2014; 147(3): 719 doi: 10.1053/j.gastro.2014.05.046
|
| 67 |
Ken Nagata, Takahiro Einama, Akifumi Kimura, Michinori Murayama, Hiroteru Takeo, Makoto Nishikawa, Mayumi Hoshikawa, Takuji Noro, Sho Ogata, Suefumi Aosasa, Yoshiki Kajiwara, Eiji Shinto, Yoshihisa Yaguchi, Shuichi Hiraki, Hironori Tsujimoto, Kazuo Hase, Hideki Ueno, Junji Yamamoto. A case of intrahepatic cholangiocarcinoma that was difficult to diagnose prior to surgery: A case report. Oncology Letters 2018; doi: 10.3892/ol.2018.9666
|
| 68 |
Shinichi Aishima, Yoshinao Oda. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2): 94 doi: 10.1002/jhbp.154
|
| 69 |
Menghua Zhou, Chaoqun Wang, Shounan Lu, Yanan Xu, Zihao Li, Hongchi Jiang, Yong Ma. Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target. EBioMedicine 2021; 67: 103375 doi: 10.1016/j.ebiom.2021.103375
|
| 70 |
Hayato Nakagawa, Yuki Hayata, Tomoharu Yamada, Satoshi Kawamura, Nobumi Suzuki, Kazuhiko Koike. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer. International Journal of Molecular Sciences 2018; 19(6): 1745 doi: 10.3390/ijms19061745
|
| 71 |
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 99 doi: 10.1007/978-3-642-40558-7_7
|
| 72 |
Jelena Djokic Kovač, Aleksandra Janković, Aleksandra Đikić-Rom, Nikica Grubor, Andrija Antić, Vladimir Dugalić. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI. Current Oncology 2022; 29(2): 698 doi: 10.3390/curroncol29020061
|
| 73 |
Jinghan Wang, Linfang Li, Keqiang Zhang, Yong Yu, Bin Li, Jiang Li, Zi Yan, Zhenli Hu, Yun Yen, Mengchao Wu, Xiaoqing Jiang, Qijun Qian, Devanand Sarkar. Characterization of Two Novel Cell Lines with Distinct Heterogeneity Derived from a Single Human Bile Duct Carcinoma. PLoS ONE 2013; 8(1): e54377 doi: 10.1371/journal.pone.0054377
|
| 74 |
Chang Hun Lee, Hong En Wang, Seung Young Seo, Seong Hun Kim, In Hee Kim, Sang Wook Kim, Soo Teik Lee, Dae Ghon Kim, Myung Kwan Han, Seung Ok Lee. Cancer related gene alterations can be detected with next-generation sequencing analysis of bile in diffusely infiltrating type cholangiocarcinoma. Experimental and Molecular Pathology 2016; 101(1): 150 doi: 10.1016/j.yexmp.2016.07.010
|
| 75 |
Marco Casadio, Francesca Biancaniello, Diletta Overi, Rosanna Venere, Guido Carpino, Eugenio Gaudio, Domenico Alvaro, Vincenzo Cardinale. Molecular Landscape and Therapeutic Strategies in Cholangiocarcinoma: An Integrated Translational Approach towards Precision Medicine. International Journal of Molecular Sciences 2021; 22(11): 5613 doi: 10.3390/ijms22115613
|
| 76 |
Sunitta Saensa-ard, Saman Leuangwattanawanit, Laddawan Senggunprai, Nisana Namwat, Sarinya Kongpetch, Yaovalux Chamgramol, Watcharin Loilome, Walaiporn Khansaard, Apinya Jusakul, Auemduan Prawan, Chawalit Pairojkul, Narong Khantikeo, Puangrat Yongvanit, Veerapol Kukongviriyapan. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand. Tumor Biology 2017; 39(11): 101042831772592 doi: 10.1177/1010428317725925
|
| 77 |
Peter L. Labib, George Goodchild, Stephen P. Pereira. Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5391-0
|
| 78 |
Hamzeh Kayhanian, Elizabeth C Smyth, Chiara Braconi. Emerging molecular targets and therapy for cholangiocarcinoma. World Journal of Gastrointestinal Oncology 2017; 9(7): 268-280 doi: 10.4251/wjgo.v9.i7.268
|
| 79 |
Silvestre Vicent, Ruby Lieshout, Anna Saborowski, Monique M. A. Verstegen, Chiara Raggi, Stefania Recalcati, Pietro Invernizzi, Luc J. W. van der Laan, Domenico Alvaro, Diego F. Calvisi, Vincenzo Cardinale. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma. Liver International 2019; 39(S1): 79 doi: 10.1111/liv.14094
|
| 80 |
Alyssa M. Krasinskas. Cholangiocarcinoma. Surgical Pathology Clinics 2018; 11(2): 403 doi: 10.1016/j.path.2018.02.005
|
| 81 |
S. Di Matteo, L. Nevi, D. Costantini, D. Overi, G. Carpino, S. Safarikia, F. Giulitti, C. Napoletano, E. Manzi, A. M. De Rose, F. Melandro, M. Bragazzi, P. B. Berloco, F. Giuliante, G. Grazi, A. Giorgi, V. Cardinale, L. Adorini, E. Gaudio, D. Alvaro, Gianfranco D. Alpini. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma. PLOS ONE 2019; 14(1): e0210077 doi: 10.1371/journal.pone.0210077
|
| 82 |
Rocio I. R. Macias. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives. ISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/828074
|
| 83 |
Alice Fraveto, Vincenzo Cardinale, Maria Consiglia Bragazzi, Felice Giuliante, Agostino Maria De Rose, Gian Luca Grazi, Chiara Napoletano, Rossella Semeraro, Anna Maria Lustri, Daniele Costantini, Lorenzo Nevi, Sabina Di Matteo, Anastasia Renzi, Guido Carpino, Eugenio Gaudio, Domenico Alvaro, Gianfranco Alpini. Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures. PLOS ONE 2015; 10(11): e0142124 doi: 10.1371/journal.pone.0142124
|
| 84 |
|
| 85 |
Nieun Seo, Do Young Kim, Jin-Young Choi. Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis. American Journal of Roentgenology 2017; 209(2): W64 doi: 10.2214/AJR.16.16923
|
| 86 |
PHANTHAKARN TIT-OON, DARANEE CHOKCHAICHAMNANKIT, AMNART KHONGMANEE, PHANEE SAWANGAREETRAKUL, JISNUSON SVASTI, CHANTRAGAN SRISOMSAP. Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional culture. International Journal of Oncology 2014; 45(5): 2108 doi: 10.3892/ijo.2014.2636
|
| 87 |
Annamaria Massa, Chiara Varamo, Francesca Vita, Simona Tavolari, Caterina Peraldo-Neia, Giovanni Brandi, Alessandro Rizzo, Giuliana Cavalloni, Massimo Aglietta. Evolution of the Experimental Models of Cholangiocarcinoma. Cancers 2020; 12(8): 2308 doi: 10.3390/cancers12082308
|